Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer Trofe-Clark

Showing results (11-20 of 45) with videos related to

Pageof 5
Sort By:
Journal of the American Society of Nephrology : JASN|September 27, 2014
Persistent BK viremia does not increase intermediate-term graft loss but is associated with de novo donor-specific antibodiesDeirdre Sawinski, Kimberly A Forde, Jennifer Trofe-Clark, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|July 14, 2020
Use of Dietary Supplements in Living Kidney Donors: A Critical ReviewAmanda K Leonberg-Yoo, David Johnson, Nicole Persun, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|February 18, 2025
Evaluating Adverse Effects of Dapsone in Solid Organ TransplantsKevin D He, Linh Nguyen, Maxwell Norris, et al.
Human Immunology|March 13, 2017
Histopathologic changes in anti-angiotensin II type 1 receptor antibody-positive kidney transplant recipients with acute rejection and no donor specific HLA antibodiesMary Ann Lim, Matthew Palmer, Jennifer Trofe-Clark, et al.
Clinical Chemistry|May 29, 2016
Systematic Review of Calcineurin Inhibitor Monitoring and Dosing Strategies in Renal Transplantation: Notice of a New Report Funded by the Agency for Healthcare Research and QualitySony Tuteja, Stacey Uhl, Brian F Leas, et al.
Clinical Transplantation|March 20, 2019
Single-center, real-world experience with granulocyte colony-stimulating factor for management of leukopenia following kidney transplantationStephanie Hamel, Vicky Kuo, Deirdre Sawinski, et al.
Clinical Transplantation|April 15, 2025
Decreasing the Risk of Early Sub-Therapeutic Tacrolimus Troughs on Short-Term Outcomes in Low-Moderate Risk Kidney Transplant Recipients Receiving Rabbit Anti-Thymocyte Globulin InductionXinqi Liu, Jennifer Trofe-Clark, Deirdre Sawinski, et al.
Clinical Transplantation|April 13, 2022
Tolerability of mycophenolate mofetil in elderly kidney transplant recipients: A retrospective cohort studyStephanie Witek, Gregory Malat, Deirdre Sawinski, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|November 27, 2024
Alternative Pneumocystis Pneumonia Prophylaxis in Solid Organ TransplantsKevin D He, Linh Nguyen, Maxwell Norris, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|November 23, 2017
Results of ASERTAA, a Randomized Prospective Crossover Pharmacogenetic Study of Immediate-Release Versus Extended-Release Tacrolimus in African American Kidney Transplant RecipientsJennifer Trofe-Clark, Daniel C Brennan, Patricia West-Thielke, et al.
Pageof 5

Showing results (11-20 of 45) with videos related to

Sort By:
Pageof 5
Journal of the American Society of Nephrology : JASN|September 27, 2014
Persistent BK viremia does not increase intermediate-term graft loss but is associated with de novo donor-specific antibodiesDeirdre Sawinski, Kimberly A Forde, Jennifer Trofe-Clark, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|July 14, 2020
Use of Dietary Supplements in Living Kidney Donors: A Critical ReviewAmanda K Leonberg-Yoo, David Johnson, Nicole Persun, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|February 18, 2025
Evaluating Adverse Effects of Dapsone in Solid Organ TransplantsKevin D He, Linh Nguyen, Maxwell Norris, et al.
Human Immunology|March 13, 2017
Histopathologic changes in anti-angiotensin II type 1 receptor antibody-positive kidney transplant recipients with acute rejection and no donor specific HLA antibodiesMary Ann Lim, Matthew Palmer, Jennifer Trofe-Clark, et al.
Clinical Chemistry|May 29, 2016
Systematic Review of Calcineurin Inhibitor Monitoring and Dosing Strategies in Renal Transplantation: Notice of a New Report Funded by the Agency for Healthcare Research and QualitySony Tuteja, Stacey Uhl, Brian F Leas, et al.
Clinical Transplantation|March 20, 2019
Single-center, real-world experience with granulocyte colony-stimulating factor for management of leukopenia following kidney transplantationStephanie Hamel, Vicky Kuo, Deirdre Sawinski, et al.
Clinical Transplantation|April 15, 2025
Decreasing the Risk of Early Sub-Therapeutic Tacrolimus Troughs on Short-Term Outcomes in Low-Moderate Risk Kidney Transplant Recipients Receiving Rabbit Anti-Thymocyte Globulin InductionXinqi Liu, Jennifer Trofe-Clark, Deirdre Sawinski, et al.
Clinical Transplantation|April 13, 2022
Tolerability of mycophenolate mofetil in elderly kidney transplant recipients: A retrospective cohort studyStephanie Witek, Gregory Malat, Deirdre Sawinski, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|November 27, 2024
Alternative Pneumocystis Pneumonia Prophylaxis in Solid Organ TransplantsKevin D He, Linh Nguyen, Maxwell Norris, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|November 23, 2017
Results of ASERTAA, a Randomized Prospective Crossover Pharmacogenetic Study of Immediate-Release Versus Extended-Release Tacrolimus in African American Kidney Transplant RecipientsJennifer Trofe-Clark, Daniel C Brennan, Patricia West-Thielke, et al.
Pageof 5